HERCULES, CA--(Marketwired - Jun 12, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced it ...
* Bio Rad Laboratories Inc - has received U.S. Food and Drug Administration clearance for its Bioplex 2200 syphilis total & RPR assay Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback